Letter: More Time Communicating

John Wilkes' call for scientists to communicate more with the public (The Scientist, Jan. 8, 1990, page 15) is an excellent idea, but he seems to underestimate the negative consequences. In addition to being ignored by promotion and tenure committees for their popular writing and becoming the object of ridicule by colleagues, there is often open contempt shown for scientists who write for popular audiences. The recommendation to write a letter to the local newspaper sounds great, since a scient

Written byDavid Hershey
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

John Wilkes' call for scientists to communicate more with the public (The Scientist, Jan. 8, 1990, page 15) is an excellent idea, but he seems to underestimate the negative consequences. In addition to being ignored by promotion and tenure committees for their popular writing and becoming the object of ridicule by colleagues, there is often open contempt shown for scientists who write for popular audiences. The recommendation to write a letter to the local newspaper sounds great, since a scientific viewpoint is too often absent from popular publications. However, writing letters is not without negative aspects, which include having your letter edited to say something other than what you meant, being ignored completely, or offending a large audience. Having submitted more than 90 letters to the editor for a combination of popular and scientific periodicals and having more than half published, I can attest to the disadvantages. Fortunately, the advantages ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies